Search Results | Cancer Research | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Cardioprotective effects of the novel anthracycline antitumor agent N-benzyladriamycin-14-valerate (AD 198)

Len Lothstein, Polly A. Hofmann, Trevor W. Sweatman, Jennifer D. Bilyeu, Ganesh R. Panta, Mervyn Israel, Judith E. Soberman, Marcello Arsura

Cancer Res (2004) 64 (7_Supplement): 258–259.

Published: 01 April 2004

View article

Journal Articles

Circumvention of Bcr-Abl kinase-mediated resistance in human leukemia cells by the PKC activator N-benzyladriamycin-14-valerate (AD 198)

Len Lothstein, Luydmila Savranskaya, Mervyn Israel, Trevor W. Sweatman

Cancer Res (2004) 64 (7_Supplement): 1118.

Published: 01 April 2004

View article

Journal Articles

Resistance to N-Benzyladriamycin-14-valerate in Mouse J774.2 Cells: P-Glycoprotein Expression without Reduced N-Benzyladriamycin-14-valerate Accumulation

Leonard Lothstein, Trevor W. Sweatman, Michael E. Dockter, Mervyn Israel

Cancer Res (1992) 52 (12): 3409–3417.

Published: 01 June 1992

View article

Journal Articles

DNA Topoisomerase II-mediated Interaction of Doxorubicin and Daunorubicin Congeners with DNA

Annette Bodley, Leroy F. Liu, Mervyn Israel, Ramakrishnan Seshadri, Yoshihiro Koseki, Fernando C. Giuliani, Stanley Kirschenbaum, Robert Silber, Milan Potmesil

Cancer Res (1989) 49 (21): 5969–5978.

Published: 01 November 1989

View article

Journal Articles

Nucleoside Uptake and Membrane Fluidity Studies on N-Trifluoroacetyladriamycin-14-O-hemiadipate-treated Human Leukemia and Lymphoma Cells

Jelveh Lameh, Ronald Y. Chuang, Mervyn Israel, Linda F. Chuang

Cancer Res (1989) 49 (11): 2905–2908.

Published: 01 June 1989

View article

Journal Articles

Effects of New N-Alkyl Analogues of Adriamycin on in Vitro Survival and Cell Cycle Progression of L1210 Cells

Frank Traganos, Mervyn Israel, Robert Silber, Ramakrishnan Seshadri, Stanley Kirschenbaum, Milan Potmesil

Cancer Res (1985) 45 (12_Part_1): 6273–6279.

Published: 01 December 1985

View article

Journal Articles

Relationship of Adriamycin Concentrations to the DNA Lesions Induced in Hypoxic and Euoxic L1210 Cells

Milan Potmesil, Stanley Kirschenbaum, Mervyn Israel, Mark Levin, Vinod K. Khetarpal, Robert Silber

Cancer Res (1983) 43 (8): 3528–3533.

Published: 01 August 1983

View article

Journal Articles

Comparative Effects of Adriamycin and N-Trifluoroacetyladriamycin-14-valerate on Cell Kinetics, Chromosomal Damage, and Macromolecular Synthesis in Vitro

Awtar Krishan, Kamla Dutt, Mervyn Israel, Ram Ganapathi

Cancer Res (1981) 41 (7): 2745–2750.

Published: 01 July 1981

View article

Journal Articles

Protein-associated DNA Breaks and DNA-Protein Cross-Links Caused by DNA Nonbinding Derivatives of Adriamycin in L1210 Cells

Mark Levin, Robert Silber, Mervyn Israel, Anna Goldfeder, Vinod K. Khetarpal, Milan Potmesil

Cancer Res (1981) 41 (3): 1006–1010.

Published: 01 March 1981

View article

Journal Articles

Structural and Functional Effects of Adriamycin on Cardiac Cells in Vitro

Theodore J. Lampidis, I. Craig Henderson, Mervyn Israel, George P. Canellos

Cancer Res (1980) 40 (11): 3901–3909.

Published: 01 November 1980

View article

Journal Articles

A Clinical-Pharmacological Evaluation of Hepatic Arterial Infusion of Adriamycin

Marc B. Garnick, William D. Ensminger, Mervyn Israel

Cancer Res (1979) 39 (10): 4105–4110.

Published: 01 October 1979

View article

Journal Articles

Effect of Adriamycin and Analogs on the Nuclear Fluorescence of Propidium Iodide-stained Cells

Awtar Krishan, Ram N. Ganapathi, Mervyn Israel

Cancer Res (1978) 38 (11_Part_1): 3656–3662.

Published: 01 November 1978

View article

Journal Articles

Hepatobiliary Metabolism and Excretion of Adriamycin and N-Trifluoroacetyladriamycin-14-valerate in the Rat

Mervyn Israel, Peter M. Wilkinson, William J. Pegg, Emil Frei, III

Cancer Res (1978) 38 (2): 365–370.

Published: 01 February 1978

View article

Journal Articles

Differences in Cellular Uptake and Cytofluorescence of Adriamycin and N-Trifluoroacetyladriamycin-14-valerate

Awtar Krishan, Mervyn Israel, Edward J. Modest, Emil Frei, III

Cancer Res (1976) 36 (6): 2108–2110.

Published: 01 June 1976

View article

Journal Articles

N-Trifluoroacetyladriamycin-14-valerate, an Analog with Greater Experimental Antitumor Activity and Less Toxicity than Adriamycin

Mervyn Israel, Edward J. Modest, Emil Frei, III

Cancer Res (1975) 35 (5): 1365–1368.

Published: 01 May 1975

View article

NARROW

Cardioprotective effects of the novel anthracycline antitumor agent N-benzyladriamycin-14-valerate (AD 198)

Circumvention of Bcr-Abl kinase-mediated resistance in human leukemia cells by the PKC activator N-benzyladriamycin-14-valerate (AD 198)

Resistance to N-Benzyladriamycin-14-valerate in Mouse J774.2 Cells: P-Glycoprotein Expression without Reduced N-Benzyladriamycin-14-valerate Accumulation

DNA Topoisomerase II-mediated Interaction of Doxorubicin and Daunorubicin Congeners with DNA

Nucleoside Uptake and Membrane Fluidity Studies on N-Trifluoroacetyladriamycin-14-O-hemiadipate-treated Human Leukemia and Lymphoma Cells

Effects of New N-Alkyl Analogues of Adriamycin on in Vitro Survival and Cell Cycle Progression of L1210 Cells

Relationship of Adriamycin Concentrations to the DNA Lesions Induced in Hypoxic and Euoxic L1210 Cells

Comparative Effects of Adriamycin and N-Trifluoroacetyladriamycin-14-valerate on Cell Kinetics, Chromosomal Damage, and Macromolecular Synthesis in Vitro

Protein-associated DNA Breaks and DNA-Protein Cross-Links Caused by DNA Nonbinding Derivatives of Adriamycin in L1210 Cells

Structural and Functional Effects of Adriamycin on Cardiac Cells in Vitro

A Clinical-Pharmacological Evaluation of Hepatic Arterial Infusion of Adriamycin

Effect of Adriamycin and Analogs on the Nuclear Fluorescence of Propidium Iodide-stained Cells

Hepatobiliary Metabolism and Excretion of Adriamycin and N-Trifluoroacetyladriamycin-14-valerate in the Rat

Differences in Cellular Uptake and Cytofluorescence of Adriamycin and N-Trifluoroacetyladriamycin-14-valerate

N-Trifluoroacetyladriamycin-14-valerate, an Analog with Greater Experimental Antitumor Activity and Less Toxicity than Adriamycin

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only